Please login to the form below

Not currently logged in

Ex-AZ CFO Jonathan Symonds joins Novartis

Novartis has announced that Jonathan Symonds, former CFO at AstraZeneca will join the Swiss group as deputy CFO and CFO designate

Novartis has announced that Jonathan Symonds, former chief financial officer (CFO) at AstraZeneca and current MD of investment banking at Goldman Sachs, will join the Swiss group as deputy CFO and CFO designate.

Symonds will join Novartis on September 1, and will report to the current CFO Raymond Breu who will retire on March 31, 2010.

"Jonathan Symonds' financial expertise, broad industry experience and deep knowledge of the healthcare industry make him especially suited to take on the responsibilities of CFO of Novartis from Raymund Breu," said Dr Daniel Vasella, chairman and CEO.

Symonds will join Novartis from global financial services firm Goldman Sachs where he has been MD of investment banking since leaving AstraZeneca in 2007.

During his eight years at AstraZeneca, Symonds oversaw the original merger between Astra and Zeneca as well as the acquisitions of several other companies.

13th May 2009


Featured jobs

Subscribe to our email news alerts


Add my company

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...